🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some experts stated the popularity for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Material Elimination

Based on the social media company, the platform has taken down problematic content and banned related keywords and query recommendations. The organization stated it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, glowing testimonials and detailed instructions for mixing or administering at residence.

After moments of joining one group, a seller posted WhatsApp details, where most purchases occur. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, health issues or previous experience.

Item Information and Costs

Within these groups, messages show dark colored parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has already seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially significant medical dangers”.